Cargando…
Metabolic remodelling in diabetic cardiomyopathy
Diabetes is a risk factor for heart failure and cardiovascular mortality with specific changes to myocardial metabolism, energetics, structure, and function. The gradual impairment of insulin production and signalling in diabetes is associated with elevated plasma fatty acids and increased myocardia...
Autores principales: | Chong, Cher-Rin, Clarke, Kieran, Levelt, Eylem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412022/ https://www.ncbi.nlm.nih.gov/pubmed/28177068 http://dx.doi.org/10.1093/cvr/cvx018 |
Ejemplares similares
-
Genetic advances in sarcomeric cardiomyopathies: state of the art
por: Ho, Carolyn Y., et al.
Publicado: (2015) -
Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes
por: Eschenhagen, Thomas, et al.
Publicado: (2015) -
Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy
por: van der Voorn, Stephanie M, et al.
Publicado: (2020) -
MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review
por: Levelt, Eylem, et al.
Publicado: (2018) -
Dendrite remodeling according to GARP
por: Shin, Grace Ji-eun, et al.
Publicado: (2022)